Search Results - "Loft, H."

Treatment effects on residual cognitive symptoms among partially or fully remitted patients with major depressive disorder: A randomized, double-blinded, exploratory study with vortioxetine by Nierenberg, A.A., Loft, H., Olsen, C.K.

“…•We investigated the treatment of residual cognitive symptoms in remitted depression.•Remitted patients improved, with no statistically significant treatment…”
Get full text

The Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials by McIntyre, RS, Harrison, J, Loft, H, Jacobson, W, Olsen, CK

“…Background: Management of cognitive deficits in Major Depressive Disorder (MDD) remains an important unmet need. This meta-analysis evaluated the effects of…”
Get full text

Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis by Gauthier, S., Loft, H., Cummings, J.

“…Introduction Behavioural disturbances are a common and distressing aspect of Alzheimer's disease (AD). This pooled analysis evaluated the specific benefits of…”
Get full text

Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study by Bakchine, S, Loft, H

“…Memantine is a moderate affinity, uncompetitive NMDA receptor antagonist currently approved for the treatment of moderate to severe Alzheimer's disease (AD). A…”
Get more information

Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study by Bakchine, S, Loft, H

“…Memantine is a moderate affinity, uncompetitive NMDA receptor antagonist currently approved for the treatment of moderate to severe Alzheimer's disease (AD). A…”
Get more information

P.2.h.009 Maintenance of vortioxetine efficacy with long-term treatment of patients with major depressive disorder by Vieta, E, Loft, H, Florea, I

Get full text

P.2.h.008 Effectiveness of long-term vortioxetine treatment of patients with major depressive disorder: subgroup analyses by Vieta, E, Loft, H, Florea, I

Get full text

P.2.f.023 The efficacy of vortioxetine in the treatment of patients with major depressive disorder (MDD) in short-term placebo-controlled studies: a meta-analysis of 11 studies by Vieta, E, Loft, H, Mahableshwarkar, A.R, Florea, I

Get full text

P.2.f.020 The efficacy of vortioxetine in treating patients with severe depression or with depression and high level of anxiety symptoms by Baldwin, D.S, Loft, H, Jacobsen, P.L, Florea, I

Get full text

P.2.h.011 Meta-analysis of cognitive function in vortioxetine clinical trials in major depressive disorder by McIntyre, R, Harrison, J, Loft, H, Jacobson, W, Olsen, C

Get full text

P.4.a.003 Prevention of relapse in adult patients with generalised anxiety disorder after response to the multimodal psychotropic agent Lu AA21004 by Baldwin, D.S, Loft, H, Florea, I

Get full text

P.2.c.010 The multimodal antidepressant Lu AA21004: open-label long-term safety and tolerability study in major depressive disorder by Florea, I, Dragheim, M, Loft, H

Get full text

P.2.f.005 Vortioxetine effects on overall patient functioning in patients with major depressive disorder by Florea, I, Loft, H, Danchenko, N, Rive, B, Brignone, M, Merikle, E, Sheehan, D.V, Jacobsen, P.L

Get full text

Short-term treatment with gaboxadol improves sleep maintenance and enhances slow wave sleep in adult patients with primary insomnia by LUNDAHL, J, STANER, L, STANER, C, LOFT, H, DEACON, S

“…Gaboxadol is a selective extrasynaptic GABA(A) agonist, previously in development for the treatment of insomniac patients. To evaluate the acute efficacy and…”
Get full text

Strategic health communication on social media: Insights from a Danish social media campaign to address HPV vaccination hesitancy by Pedersen, Eva A., Loft, Louise H., Jacobsen, Stine U., Søborg, Bolette, Bigaard, Janne

“…•A social media strategy proved useful in a campaign about HPV vaccination.•Heart-brain communication is effective in creating dialogues with target…”
Get full text

Using Facebook to increase coverage of HPV vaccination among Danish girls: An assessment of a Danish social media campaign by Loft, Louise H., Pedersen, Eva A., Jacobsen, Stine U., Søborg, Bolette, Bigaard, Janne

“…In this study we assess how different Facebook (FB) posts resonate with parents hesitant about HPV vaccination and how to engage parents in positive dialogues…”
Get full text

P.2.c.024 A double-blind, randomised, placebocontrolled, relapse-prevention study with Lu AA21004 in patients with major depressive disorder by Dragheim, M, Loft, H, Florea, I, Boulenger, J.P

Get full text

P.2.c.013 A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in MDD treatment by Baldwin, D, Loft, H, Dragheim, M

Get full text

The effect of vortioxetine (LU AA21004) on health-related quality of life (HRQOL) in patients with major depressive disorder (MDD) by Florea, I, Danchenko, N, Loft, H, Rive, B, Pendlebury, S, Abetz, L

Get full text

Oral clodronate in breast cancer patients with bone metastases: a randomized study by Kristensen, B., Ejlertsen, B., Groenvold, M., Hein, S., Loft, H., Mouridsen, H. T.

“…Objectives. To investigate the effect of the bisphosphonate clodronate on the occurrence of skeletal events (hypercalcaemia, fractures and radiotherapy) in…”
Get full text